Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lenka Ostrizkova"'
Autor:
Monika, Hajkova, Tomas, Andrasina, Petra, Ovesna, Tomas, Rohan, Marek, Dostal, Vlastimil, Valek, Lenka, Ostrizkova, Stepan, Tucek, Jiri, Sedo, Igor, Kiss
Publikováno v:
In Vivo
Background/Aim: To evaluate the prognostic value of Response Evaluation Criteria In Solid Tumors (RECIST), modified RECIST and volumetric analysis in patients with hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE). Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f55c1e50c8ff764c49ad798a605d1b
https://doi.org/10.21873/invivo.12964
https://doi.org/10.21873/invivo.12964
Autor:
Tomas Andrasina, Tomas Rohan, Jiri Panek, Petra Kovalcikova, Lumir Kunovsky, Lenka Ostrizkova, Vlastimil Valek
Publikováno v:
European Journal of Radiology. 148:110180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c50f9b2b1e83ddab2003e891fbb6b68a
https://doi.org/10.1016/j.ejrad.2022.110180
https://doi.org/10.1016/j.ejrad.2022.110180
Autor:
Tomáš Rohan, Petra Kovalcikova, Vlastimil Válek, Tomáš Andrašina, Lenka Ostrizkova, Jiri Panek, Lumir Kunovsky
Publikováno v:
European Journal of Radiology. 142:109830
Purpose To analyse whether endobiliary radiofrequency ablation prior metal stent insertion in malignant biliary stenosis show improved survival or stent patency. Methods 76 patients with histologically proven malignant biliary stenosis have been enro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7362895f7799d32f6256455b7704ee
https://doi.org/10.1016/j.ejrad.2021.109830
https://doi.org/10.1016/j.ejrad.2021.109830
Autor:
Lumir Kunovsky, Vladimir Prochazka, Zdenek Kala, Jan Hlavsa, Jiri Dolina, Hana Maskova, Michal Senkyrik, Tomas Andrasina, Alexandra Litavcova, Jan Mazanec, Lenka Ostrizkova, Michal Eid, Petra Kovalcikova, Tomas Pavlik, Petr Dite
Publikováno v:
Pancreatology. 19:S35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c5666eeb5065e9c4edc95ed8efc2b0f
https://doi.org/10.1016/j.pan.2019.05.087
https://doi.org/10.1016/j.pan.2019.05.087
Autor:
Beatric Benscikova, Lenka Ostrizkova, Karel Hejduk, Lubos Petruzelka, Michal Vocka, Radka Obermannova, Lenka Zdrazilova-Dubska, Igor Kiss, Renata Chloupková
Publikováno v:
Journal of Clinical Oncology. 36:785-785
785 Background: Right-sided location of primary colorectal carcinoma is associated with worse prognosis and predicts worse outcome of treatment of metastatic disease. Prognostic role of KRAS status in 1st-line treatment with anti-VEGF of mCRC remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50725dc41518844ba93da017e4aebc5f
https://doi.org/10.1200/jco.2018.36.4_suppl.785
https://doi.org/10.1200/jco.2018.36.4_suppl.785
Autor:
Lenka Zdrazilova-Dubska, Beatrix Bencsiková, Igor Kiss, Rostislav Vyzula, Zbynek Bortlicek, Dalibor Valík, Bohuslav Melichar, Tomáš Pavlík, Ladislav Dušek, Jana Halámková, Lenka Ostrizkova
Publikováno v:
BMC Gastroenterology
Background The aim of the present retrospective study was to analyze clinical outcome and risk factors associated with treatment outcomes according to KRAS status in patient with metastatic colorectal cancer (mCRC) treated with bevacizumab (bev) plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e474868f86869ccc4e416db57dfbbb9
http://europepmc.org/articles/PMC4376345
http://europepmc.org/articles/PMC4376345
Autor:
Karel Hejduk, Michal Vocka, Lubos Petruzelka, Lenka Zdrazilova-Dubska, Dagmar Brančíková, Lenka Ostrizkova, Rostislav Vyzula, Beatrix Bencsiková, Radka Obermannova
Publikováno v:
Journal of Clinical Oncology. 35:763-763
763 Background: Anti-EGFR-antibody-based treatment is a standard of care in patients with RASwt metastatic colorectal cancer (mCRC). Right-sided mCRC is associated with frequent presence of KRAS mutation and with worse prognosis. Here we show the cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::886c5a630da1520b30b39ea4c18874b4
https://doi.org/10.1200/jco.2017.35.4_suppl.763
https://doi.org/10.1200/jco.2017.35.4_suppl.763
Publikováno v:
Journal of Clinical Oncology. 33:e17027-e17027
Background: Adeoid cystic carcinomas of the salivary gland account for approximately 10% of parotid gland tumors. Well-differentiated tumors are characterized by a slow growth rate, a low recurrence rate after complete surgical excision and rare meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::decb6f078e96fac5b55bb3f7e39719d2
https://doi.org/10.1200/jco.2015.33.15_suppl.e17027
https://doi.org/10.1200/jco.2015.33.15_suppl.e17027
Autor:
Lenka, Ostrizkova, Zdenek, Mechl, Dagmar, Brancikova, Otakar, Bednarik, Marketa, Protivankova
Publikováno v:
In Annals of Oncology June 2014 25 Supplement 2:ii92-ii92
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.